NETZ, TRANSKRIPTIONSFAKTOR DER TCF-FAMILIE ALS REGULATOR DER ANGIOGENISCHEN FAKTOREXPRESSION

The present invention relates to the regulation of the activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity. The invention further relates to methods of screening for agonists or antagonists of NET in order to identify new pro-angiogenic or anti-angiogen...

Full description

Saved in:
Bibliographic Details
Main Authors ZHENG, HONG, AYADI, ABDELKADER, WASYLYK, BOHDAN, MULTON, MARIERISTINE
Format Patent
LanguageGerman
Published 04.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the regulation of the activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity. The invention further relates to methods of screening for agonists or antagonists of NET in order to identify new pro-angiogenic or anti-angiogenic compounds and to therapeutic uses of these compounds. The invention also relates to transgenic animals bearing mutations in NET gene.
Bibliography:Application Number: DE20016025574T